TXG FY2025 SEC EDGAR DEF 14A #76 of 86 in industry

10x Genomics, Inc. CEO pay ratio

The CEO earned $6.3M in FY2025 against median worker pay of $196,532 · Measuring Instruments.

Measuring Instruments peers All rankings
State
DE
Filing date
2026-04-24
Industry
Measuring Instruments
Industry rank
#76/86

Data updated August 2026

Subscribe to 10x Genomics, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
32:1
Below Average (Scale: 0–1000:1)
CEO pay
$6.3M
Median worker
$196,532

Answer first

10x Genomics, Inc.'s FY2025 CEO total of $6.3M ranks #821 of 1,423 complete filings; its 32:1 pay ratio ranks #1122. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $196,532. Industry placement uses the FY2025 SIC-38 peer cohort (# 76 of 86, 13th percentile - among the lower quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Measuring Instruments companies.

Dollar rank
#821
$6.3M of 1,423 FY2025
Ratio rank
#1122
32:1 of 1,423
Industry pct
13th
among the lower quartile of industry peers by pay ratio

How 10x Genomics, Inc. ranks nationally

10x Genomics, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$6,329,244 42nd percentile higher than 42% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). This entry sits in this band. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

10x Genomics, Inc. vs. Measuring Instruments peers

CEO total pay ($6.3M) against pay ratio (32:1) for 10x Genomics, Inc. (marked) and its 5 closest same-industry peers, against the Measuring Instruments industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both02105664.54211328.96316993.48422657.923.4:148.8:174.3:199.7:1125.1:1CEO total payPay ratio (CEO : median worker)10x Genomics, Inc., CEO total pay: 6329244 · Pay ratio (CEO : median worker): 32:110x Genomics, Inc.Globus Medical Inc, CEO total pay: 128616 · Pay ratio (CEO : median worker): 35:1Globus Medical IncInspire Medical Systems, Inc., CEO total pay: 7711784 · Pay ratio (CEO : median worker): 35:1Inspire Medical Systems, Inc.Treace Medical Concepts, Inc., CEO total pay: 5369875 · Pay ratio (CEO : median worker): 35:1Treace Medical Concepts, Inc.RxSight, Inc., CEO total pay: 4615744 · Pay ratio (CEO : median worker): 28:1RxSight, Inc.Tactile Systems Technology Inc, CEO total pay: 3444363 · Pay ratio (CEO : median worker): 39:1Tactile Systems Technology Inc
10x Genomics, Inc. vs. Measuring Instruments peers, plotted against the industry's $8.0M median CEO total and 121:1 median pay ratio.

Ratio bands among Measuring Instruments peers

Exclusive CEO-to-median-worker bands across 80 complete latest-FY filings in SIC 38. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in 10x Genomics, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · 10x Genomics, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
32:1
FY2025
vs prior FY
-7:1
from FY2024 39:1
CEO $ YoY
-20%
$6.3M latest
Filings shown
5
FY2021–2025
10x Genomics, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $11.7M - $246,380 47:1 -
2022 $18.8M +61% $252,567 74:1 +27:1
2023 $8.3M -56% $223,138 37:1 -37:1
2024 $7.9M -4.3% $205,000 39:1 +2:1
2025 $6.3M -20% $196,532 32:1 -7:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1770787, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Measuring Instruments

This Company's Ratio
32:1
Industry Median Ratio
121:1
Industry Median CEO Pay
$8.0M
This CEO's Pay
$6.3M
Companies in Industry
86
vs. Industry Median
Below
#76 of 86 by pay ratio in this industry View all companies in Measuring Instruments →

10x Genomics, Inc.: MODEST · HEAVY pay ratio

10x Genomics, Inc.'s FY2025 ratio 32:1 ranks #76 of 86 Measuring Instruments filers (13th percentile). the CEO earned 32× the median employee ($196,532) in FY2025.

Median employee $196,532 (ELITE-MED); MODEST · HEAVY stamps put about 32 median-wage years per CEO year.

CEO Total Pay

$6.3M

FY2025 Summary Compensation, below median

Pay Ratio

32:1

Below typical

10x Genomics, Inc. in the lower Measuring Instruments third

10x Genomics, Inc.'s FY2025 ratio 32:1 ranks #76 of 86 Measuring Instruments filers (13th percentile). The structured pay-ratio disclosure reports the total without line-item components. Measuring Instruments (SIC 38) median ratio is 121:1 across 86 FY2025 filers; 10x Genomics, Inc.'s $6.3M CEO total is at or below the $8.0M industry median CEO pay.

Dollar rank #821 and ratio rank #1122 split - treat 32:1 as a disclosure, not a fairness score. Open Measuring Instruments peers.

Key Data, FY2025

Total Compensation
$6.3M
Median Employee Pay
$196,532
Pay Ratio
32:1
Filing Date
2026-04-24

Company Info

Ticker
TXG
CIK
1770787
Industry
Measuring Instruments
SIC Code
3826
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1770787, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. 10x Genomics, Inc.'s FY2025 ratio 32:1 ranks #76 of 86 Measuring Instruments filers (13th percentile).

Read with 10x Genomics, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · HEAVY · ELITE-MED.

Compass Minerals International Inc · HEAVY

ABS(ceo_total_comp) peer at $6.3M (Δ $5K heavier vs 10x Genomics, Inc.); MODEST · HIGH-MED vs this page's MODEST · HEAVY · ELITE-MED.
Saia Inc · HEAVY

ABS(ceo_total_comp) peer at $6.3M (Δ $16K lighter vs 10x Genomics, Inc.); MID · PAR-MED vs this page's MODEST · HEAVY · ELITE-MED.
AbCellera Biologics Inc. · HEAVY

ABS(ceo_total_comp) peer at $6.4M (Δ $21K heavier vs 10x Genomics, Inc.); MODEST · ELITE-MED vs this page's MODEST · HEAVY · ELITE-MED.
Nurix Therapeutics, Inc. · HEAVY

ABS(ceo_total_comp) peer at $6.3M (Δ $21K lighter vs 10x Genomics, Inc.); FLOOR · ELITE-MED vs this page's MODEST · HEAVY · ELITE-MED.
Globus Medical Inc (SIC 38 pole)

Globus Medical Inc stamps MODEST · MICRO nearest in-SIC by ABS(pay_ratio) to 10x Genomics, Inc.'s MODEST filing.
National dual ranks · #821/#1122

10x Genomics, Inc.'s FY2025 package sits #821 by CEO dollars and #1122 by ratio under HEAVY · MODEST.
Ratio primer · MODEST

10x Genomics, Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for 10x Genomics, Inc. (CIK 1770787), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.